Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00083212
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
368 | (1R)-2-{[AMINO(IMINO)METHYL]AMINO}- 1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2- DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE | A | 1ZLR | 0.72 | |
PYC | PYRROLE-2-CARBOXYLATE | A | 1W62 | 0.7 | |
PYC | PYRROLE-2-CARBOXYLATE | A,B | 1L9D | 0.7 | |
PYC | PYRROLE-2-CARBOXYLATE | A,B | 2CWH | 0.7 | |
PYC | PYRROLE-2-CARBOXYLATE | A,B | 1W61 | 0.7 | |
PYC | PYRROLE-2-CARBOXYLATE | A,B | 1ELI | 0.7 | |
2CA | BENZOFURAN-2-CARBOXYLIC ACID {(S)- 3-METHYL-1-[3-OXO-1-(PYRIDIN-2- YLSULFONYL)AZEPAN-4-YLCARBAMOYL]BUTYL}AMIDE | A,B | 1NLJ | 0.72 | |
897 | N-[3-(TERT-BUTYLAMINO)-3-OXOPROPYL]- N-ISOPROPYL-3-METHYL-5-{[(2S)-2- (PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE | B,H | 2UUK | 0.76 | |
H35 | N-(FURAN-2-YLMETHYL)-7H-PURIN-6- AMINE | A | 2UY5 | 0.71 | |
D2G | N-METHYL(5-(PYRIDIN-3-YL)FURAN- 2-YL)METHANAMINE | A,B,C,D | 2FDV | 0.9 | |
721 | 3-butoxy-1-(2,2-diphosphonoethyl)pyridinium | A,B | 3DYH | 0.71 | |
POS | 1-[[(4-PHENOXYPHENYL)SULFONYL]AMINO]- 3-[[N/N-(4-PYRIDINYLCARBONYL)-L- LEUCYL]AMINO]-2-PROPANOL | A | 1AU2 | 0.74 | |
NNR | Nicotinamide riboside | A | 2QT0 | 0.71 | |
NNR | Nicotinamide riboside | A | 2QT1 | 0.71 | |
BI5 | 4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE | A | 1ZYJ | 0.78 | |
ILI | N-[(1S)-1-({[(3S,4S,7R)-3-HYDROXY- 7-METHYL-1-(PYRIDIN-2-YLSULFONYL)- 2,3,4,7-TETRAHYDRO-1H-AZEPIN-4- YL]AMINO}CARBONYL)-3-METHYLBUTYL]- 1-BENZOFURAN-2-CARBOXAMIDE | A,B | 2FTD | 0.71 | |
NIO | NICOTINIC ACID | A | 1JHQ | 0.7 | |
NIO | NICOTINIC ACID | A | 1L5L | 0.7 | |
NIO | NICOTINIC ACID | A | 2F7F | 0.7 | |
NIO | NICOTINIC ACID | A | 1L5K | 0.7 | |
NIO | NICOTINIC ACID | A | 1JHY | 0.7 | |
NIO | NICOTINIC ACID | A,B | 1FSL | 0.7 | |
NIO | NICOTINIC ACID | A | 1L5M | 0.7 | |
NIO | NICOTINIC ACID | A | 1LH6 | 0.7 | |
NIO | NICOTINIC ACID | A | 1JHO | 0.7 | |
NIO | NICOTINIC ACID | A | 3CI8 | 0.7 | |
NIO | NICOTINIC ACID | A,B,C,D | 1ICU | 0.7 | |
NIO | NICOTINIC ACID | A,B,C,D,E,F, G,H | 3HRD | 0.7 | |
NIO | NICOTINIC ACID | A | 1JHA | 0.7 | |
NIO | NICOTINIC ACID | A | 1JHV | 0.7 | |
NIO | NICOTINIC ACID | A | 1L4N | 0.7 | |
NIO | NICOTINIC ACID | A | 2LH6 | 0.7 | |
NIO | NICOTINIC ACID | A | 1D0V | 0.7 | |
NIO | NICOTINIC ACID | A,B,C,D | 1ICV | 0.7 | |
NIO | NICOTINIC ACID | A,B | 1ICR | 0.7 | |
NIO | NICOTINIC ACID | A | 1JHR | 0.7 | |
LI4 | 3-(1-NAPHTHYLMETHOXY)PYRIDIN-2- AMINE | A | 1WBW | 0.71 | |
D1G | N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN- 2-YL)METHANAMINE | A,B,C,D | 2FDU | 0.87 | |
893 | 5-CYANO-N-(2,5-DIMETHOXYBENZYL)- 6-ETHOXYPYRIDINE-2-CARBOXAMIDE | A,B | 2H96 | 0.71 | |
896 | N-ETHYL-N-ISOPROPYL-3-METHYL-5- {[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE | B,H | 2UUJ | 0.78 | |
D3G | (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE | A,B,C,D | 2FDW | 0.88 | |
750 | 5-(2-MORPHOLIN-4-YLETHOXY)BENZOFURAN- 2-CARBOXYLIC ACID ((S)-3-METHYL- 1-{(S)-3-OXO-1-[2-(3-PYRIDIN-2- YLPHENYL)ACETYL]AZEPAN-4-YLCARBAMOYL}BUTYL)AMIDE | A,B | 1NL6 | 0.7 | |
282 | 3-methoxypyridine | X | 2RBZ | 0.73 | |
L92 | (2S)-3-{4-[3-(5-METHYL-2-PHENYL- 1,3-OXAZOL-4-YL)PROPYL]PHENYL}- 2-(1H-PYRROL-1-YL)PROPANOIC ACID | A | 2Q8S | 0.71 | |
L11 | N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)- PHENYL]-3-FLUORO- | A | 1W83 | 0.7 | |
BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,D,U,X | 1FM6 | 0.7 | |
BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,B | 2PRG | 0.7 | |
BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A | 1ZGY | 0.7 | |
BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,B | 3CS8 | 0.7 | |
BRL | 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2- (METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]- (9CL) | A,D | 3DZY | 0.7 | |
4EA | (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)- 2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE | E | 2F7X | 0.72 | |
547 | 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3- B]PYRIDIN-4-AMINE | A | 2OF2 | 0.72 | |
NNO | 6-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCK | 0.71 | |
NNO | 6-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCM | 0.71 | |
FLX | N-[(FURAN-2-YL)CARBONYL]-(S)-LEUCYL- (R)-[1-AMINO-2(1H-INDOL-3-YL)ETHYL]- PHOSPHONIC ACID | A | 4AIG | 0.72 | |
4PY | (2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H- PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN- 3-YL]OXY}PROPAN-2-AMINE | E | 2OJF | 0.73 | |
PIL | 3-(CYCLOPENTYLOXY)-N-(3,5-DICHLOROPYRIDIN- 4-YL)-4-METHOXYBENZAMIDE | A,B | 1XM4 | 0.7 | |
PIL | 3-(CYCLOPENTYLOXY)-N-(3,5-DICHLOROPYRIDIN- 4-YL)-4-METHOXYBENZAMIDE | A,B | 1XON | 0.7 | |
PXA | 2-AMINO-1,9-DICARBONYL-4,6-DIMETHYL- 10-DEHYDRO-3-OXO(8-AZA)PHENOXAZINE | A | 209D | 0.7 | |
608 | N-(4-phenoxyphenyl)-2-[(pyridin- 4-ylmethyl)amino]nicotinamide | A,B | 2P2I | 0.73 | |
3IP | 3-(BENZYLOXY)PYRIDIN-2-AMINE | A | 1W7H | 0.76 |